
Medtronic PLC MDT
$ 96.07
-0.68%
Quarterly report 2025-Q4
added 02-24-2026
Medtronic PLC Interest Expense 2011-2026 | MDT
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Medtronic PLC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 402 M | 412 M | 515 M | 553 M | 925 M | 1.09 B | 1.44 B | 1.15 B | 1.09 B | 1.39 B | 666 M | 379 M | 388 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.44 B | 379 M | 800 M |
Quarterly Interest Expense Medtronic PLC
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121 M | 92 M | 33 M | - | 72 M | 173 M | 157 M | - | 177 M | 154 M | 76 M | - | 167 M | 118 M | 164 M | - | 143 M | 136 M | 273 M | - | 156 M | 470 M | 470 M | 171 M | 243 M | 165 M | 165 M | 609 M | 270 M | 241 M | 241 M | 242 M | 268 M | 273 M | 273 M | 286 M | 275 M | 264 M | 264 M | 272 M | 176 M | 324 M | 324 M | 306 M | - | 94 M | 97 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 609 M | 33 M | 219 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aziyo Biologics
AZYO
|
5.8 M | - | 1.37 % | $ 20.5 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 39.54 | 0.69 % | $ 5.89 K | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 7.94 | 1.53 % | $ 570 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
1.19 M | - | -0.97 % | $ 54.4 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 9.56 | 1.7 % | $ 1.29 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 4.0 | 0.25 % | $ 149 M | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 43.17 | -0.33 % | $ 1.34 B | ||
|
Electromed
ELMD
|
78 K | $ 23.98 | 0.25 % | $ 203 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.54 | 0.19 % | $ 122 M | ||
|
AxoGen
AXGN
|
167 K | $ 29.57 | -0.89 % | $ 1.36 B | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.28 | 3.48 % | $ 114 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Accuray Incorporated
ARAY
|
559 K | $ 0.52 | -1.44 % | $ 53.4 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 183.24 | 0.33 % | $ 13.7 B | ||
|
Inari Medical
NARI
|
294 K | - | - | $ 4.23 B | ||
|
Butterfly Network
BFLY
|
-13 K | $ 3.91 | 5.68 % | $ 828 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
548 M | $ 112.45 | -0.99 % | $ 196 B | ||
|
NuVasive
NUVA
|
-21.4 M | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
-421 K | - | - | $ 217 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 72.23 | -2.19 % | $ 107 B | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.1 | 5.81 % | $ 1.28 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 12.81 | -1.61 % | $ 1.92 B | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 104.42 | 0.12 % | $ 1.32 B | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 84.58 | -0.8 % | $ 49.5 B |